Citation: K. Bush, New beta-lactamases in gram-negative bacteria: Diversity and impact on theselection of antimicrobial therapy, CLIN INF D, 32(7), 2001, pp. 1085-1089
Citation: Rw. Sidwell et al., Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201, ANTIVIR RES, 51(3), 2001, pp. 179-187
Authors:
Drusano, GL
Preston, SL
Smee, D
Bush, K
Bailey, K
Sidwell, RW
Citation: Gl. Drusano et al., Pharmacodynamic evaluation of RWJ-270201, a novel neuraminidase inhibitor,in a lethal murine model of influenza predicts efficacy for once-daily dosing, ANTIM AG CH, 45(7), 2001, pp. 2115-2118
Authors:
Yigit, H
Queenan, AM
Anderson, GJ
Domenech-Sanchez, A
Biddle, JW
Steward, CD
Alberti, S
Bush, K
Tenover, FC
Citation: H. Yigit et al., Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae, ANTIM AG CH, 45(4), 2001, pp. 1151-1161
Authors:
Baum, EZ
Montenegro, DA
Licata, L
Turchi, I
Webb, GC
Foleno, BD
Bush, K
Citation: Ez. Baum et al., Identification and characterization of new inhibitors of the Escherichia coli MurA enzyme, ANTIM AG CH, 45(11), 2001, pp. 3182-3188
Citation: Am. Queenan et al., Cloning and biochemical characterization of FOX-5, an AmpC-type plasmid-encoded beta-lactamase from a New York City Klebsiella pneumoniae clinical isolate, ANTIM AG CH, 45(11), 2001, pp. 3189-3194
Authors:
Govorkova, EA
Leneva, IA
Goloubeva, OG
Bush, K
Webster, RG
Citation: Ea. Govorkova et al., Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir againstH5N1, H9N2, and other avian influenza viruses, ANTIM AG CH, 45(10), 2001, pp. 2723-2732
Authors:
Urban, C
Mariano, N
Rahman, N
Queenan, AM
Montenegro, D
Bush, K
Rahal, JJ
Citation: C. Urban et al., Detection of multiresistant ceftazidime-susceptible Klebsiella pneumoniae isolates lacking TEM-26 after class restriction of cephalosporins, MICROB DR R, 6(4), 2000, pp. 297-303
Citation: C. Fogarty et al., Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin, CLIN INF D, 31(2), 2000, pp. 613-615
Authors:
Queenan, AM
Torres-Viera, C
Gold, HS
Carmeli, Y
Eliopoulos, GM
Moellering, RC
Quinn, JP
Hindler, J
Medeiros, AA
Bush, K
Citation: Am. Queenan et al., SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains, ANTIM AG CH, 44(11), 2000, pp. 3035-3039
Authors:
Ahmad, M
Urban, C
Mariano, N
Bradford, PA
Calcagni, E
Projan, SJ
Bush, K
Rahal, JJ
Citation: M. Ahmad et al., Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae, CLIN INF D, 29(2), 1999, pp. 352-355
Authors:
Hilliard, JJ
Goldschmidt, RM
Licata, L
Baum, EZ
Bush, K
Citation: Jj. Hilliard et al., Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems, ANTIM AG CH, 43(7), 1999, pp. 1693-1699
Authors:
Yang, YJ
Testa, RT
Bhachech, N
Rasmussen, BA
Bush, K
Citation: Yj. Yang et al., Biochemical characterization of novel tetrahydrofuranyl 1 beta-methylcarbapenems: Stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties, ANTIM AG CH, 43(12), 1999, pp. 2904-2909
Authors:
Kelleher, RL
Zubarev, RA
Bush, K
Furie, B
Furie, BC
McLafferty, FW
Walsh, CT
Citation: Rl. Kelleher et al., Localization of labile posttranslational modifications by electron capturedissociation: The case of gamma-carboxyglutamic acid, ANALYT CHEM, 71(19), 1999, pp. 4250-4253